316 related articles for article (PubMed ID: 37252741)
21. Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.
Granvik C; Andersson S; Andersson L; Brorsson C; Forsell M; Ahlm C; Normark J; Edin A
Brain Behav; 2024 Jun; 14(6):e3574. PubMed ID: 38841730
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
25. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Tomasa-Irriguible TM; Monfà R; Miranda-Jiménez C; Morros R; Robert N; Bordejé-Laguna L; Vidal S; Torán-Monserrat P; Barriocanal AM
Nutrients; 2024 May; 16(11):. PubMed ID: 38892564
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
27. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
[TBL] [Abstract][Full Text] [Related]
28. Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial.
Elder GJ; Alfonso-Miller P; Atkinson WCM; Santhi N; Ellis JG
Trials; 2020 Aug; 21(1):704. PubMed ID: 32771068
[TBL] [Abstract][Full Text] [Related]
29. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
[TBL] [Abstract][Full Text] [Related]
30. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
32. One-Year Adverse Outcomes Among US Adults With Post-COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database.
DeVries A; Shambhu S; Sloop S; Overhage JM
JAMA Health Forum; 2023 Mar; 4(3):e230010. PubMed ID: 36867420
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
34. Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System.
Pena Orbea C; Wang L; Shah V; Jehi L; Milinovich A; Foldvary-Schaefer N; Chung MK; Mashaqi S; Aboussouan L; Seidel K; Mehra R
JAMA Netw Open; 2021 Nov; 4(11):e2134241. PubMed ID: 34757409
[TBL] [Abstract][Full Text] [Related]
35. Assessment of a Hotel-Based Protective Housing Program for Incidence of SARS-CoV-2 Infection and Management of Chronic Illness Among Persons Experiencing Homelessness.
Huggett TD; Tung EL; Cunningham M; Ghinai I; Duncan HL; McCauley ME; Detmer WM
JAMA Netw Open; 2021 Dec; 4(12):e2138464. PubMed ID: 34902035
[TBL] [Abstract][Full Text] [Related]
36. Universal screening for SARS-CoV-2 infection: a rapid review.
Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition.
Limoges MA; Quenum AJI; Chowdhury MMH; Rexhepi F; Namvarpour M; Akbari SA; Rioux-Perreault C; Nandi M; Lucier JF; Lemaire-Paquette S; Premkumar L; Durocher Y; Cantin A; Lévesque S; Dionne IJ; Menendez A; Ilangumaran S; Allard-Chamard H; Piché A; Ramanathan S
Front Immunol; 2023; 14():1223936. PubMed ID: 37809081
[TBL] [Abstract][Full Text] [Related]
38. Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona.
Ellingson KD; Gerald JK; Sun X; Hollister J; Lutrick K; Parker J; Rivers P; Beitel SC; Baccam Z; Lamberte JM; Grant L; Kim E; Bhattarai R; Komatsu K; Meece J; Kutty PK; Thompson MG; Burgess JL
JAMA Health Forum; 2021 Oct; 2(10):e213318. PubMed ID: 35977166
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.
Li Y; Tong CH; Bare LA; Devlin JJ
JAMA Netw Open; 2021 May; 4(5):e2111634. PubMed ID: 34009346
[TBL] [Abstract][Full Text] [Related]
40. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
